PURITAN-BENNETT 840 VENTILATIOR SYSTEM WITH VOLUME VENTILATION PLUS OPTION
K021573 · Puritan-Bennett · CBK · Aug 13, 2002 · Anesthesiology
Device Facts
| Record ID | K021573 |
| Device Name | PURITAN-BENNETT 840 VENTILATIOR SYSTEM WITH VOLUME VENTILATION PLUS OPTION |
| Applicant | Puritan-Bennett |
| Product Code | CBK · Anesthesiology |
| Decision Date | Aug 13, 2002 |
| Decision | ST |
| Submission Type | Special |
| Regulation | 21 CFR 868.5895 |
| Device Class | Class 2 |
| Attributes | Therapeutic, Pediatric |
Intended Use
The 840 Ventilator with Volume Ventilation Plus™ Option is used to provide continuous ventilation to patients requiring respiratory support. This device is used for a wide range of patients from infant to adult and for a wide variety of clinical conditions. The device is for prescription use only. The 840 Ventilator with Neomode and Volume Ventilation Plus™ Options provides continuous ventilation to patients requiring respiratoroy support. The Neomode Option, which is used on neonatal patients with Ideal Body Weights (IBW) as low as 0.5kg, is intended to cover a variety of clinical conditions. The 840 Ventilatory with Neomode and Volume Ventilation Plus Options is intended for use in hospital-type facilities. It may be used during hospital and hospital-type facility transport provided that electrical power and compressed gas are supplied. The device is for prescription use only.
Device Story
840 Ventilator System provides continuous invasive/non-invasive ventilation; modification adds Volume Ventilation Plus (VV+) option. VV+ introduces two breath types: VC' and VS. Device utilizes dual-microprocessor control; software-based modification to existing user interface; no hardware/firmware changes. Used in hospital/clinical settings by healthcare professionals. Output provides respiratory support; clinicians monitor ventilation parameters via interface. Benefits include automated breath delivery modes similar to predicate devices, supporting patient respiratory needs.
Clinical Evidence
Bench testing only. No clinical data provided. Substantial equivalence established through software verification testing and comparative analysis of technical characteristics against predicate devices.
Technological Characteristics
Dual-microprocessor controlled critical care ventilator. Software-based modification (VV+ option) to existing 840 platform. No hardware or firmware changes. Connectivity via existing user interface. Class II device.
Indications for Use
Indicated for continuous respiratory support in patients ranging from neonates (IBW as low as 0.5kg with Neomode) to adults. Used for various clinical conditions requiring invasive or non-invasive ventilation in hospital or hospital-type facilities.
Regulatory Classification
Identification
A continuous ventilator (respirator) is a device intended to mechanically control or assist patient breathing by delivering a predetermined percentage of oxygen in the breathing gas. Adult, pediatric, and neonatal ventilators are included in this generic type of device.
Predicate Devices
- Siemens Servo 300 with Pressure Regulated Volume Control (PRVC) and Volume support (VS) (K902859)
- Draeger Evita 4 with AutoFlow (K961687)
- Draeger Evita 2 Dura with AutoFlow (K970165)
- Hamilton Galileo with Adaptive Pressure Ventilation (APV) (K001686)
Reference Devices
- Puritan-Bennett Corp. 840 Ventilator System (K970460)
- Puritan-Bennett Corp. 840 Ventilator System with Neomode Option (K001646)
Related Devices
- K063650 — VENTILATOR WITH RESPIRATORY MECHANICS, MODEL 840 · Puritan Bennett Corp. · Feb 15, 2007
- K984535 — PURITAN-BENNETT 840 VENTILATORY SYSTEM WITH BILEVEL OPTION · Puritan Bennett Corp. · Dec 28, 1998
- K034040 — ESPRIT VENTILATOR, MODEL V1000 · Respironics, Inc. · Jan 21, 2004
- K110083 — V200 VENTILATOR WITH APRV MODE, ESPRIT VENTILATOR WITH APRV MODE · Respironics California, Inc. · Jan 13, 2012
- K083526 — TRILOGY 100 VENTILATOR · Respironics Inc., Sleep & Home Respiratory Group · Mar 13, 2009
Submission Summary (Full Text)
{0}------------------------------------------------
AUG 1 3 2002
K02/573
2200 Faraday Avenue Carlsbad, CA 92008
Tele: 925 463-4427 Fax: 925 463-4020
## 510(k) Summary
| Submitted by: | Puritan-Bennett Corporation<br>2200 Faraday Avenue<br>Carlsbad, CA 92008 |
|------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Company Contact: | Gina To<br>Senior Regulatory Affairs Project Manager<br>(925) 463-4427<br>(925) 463-4020 - FAX |
| Date Summary Prepared: | August 1, 2002 |
| Product Name: | 840 Ventilator System with Volume Ventilation Plus™<br>Option (VV+) |
| Common Name: | Ventilator |
| Classification: | Class II; Continuous Ventilator per 21 CFR §868.5895 |
| Legally Marketed<br>(Unmodified) Device: | <ul><li>Puritan-Bennett Corp. 840 Ventilator System, K970460</li><li>Puritan-Bennett Corp. 840 Ventilator System with Neomode Option, K001646</li></ul> |
| Predicate Devices: | <ul><li>Siemens Servo 300 with Pressure Regulated Volume Control (PRVC) and Volume support (VS), K902859</li><li>Draeger Evita 4 with AutoFlow, K961687</li><li>Draeger Evita 2 Dura with AutoFlow, K970165</li><li>Hamilton Galileo with Adaptive Pressure Ventilation (APV), K001686</li></ul> |
#### DEVICE DESCRIPTION
The VV+ modification provides the 840 Ventilator System with two new breath types, VC' and VS. The VV+ feature is implemented on the 840 Ventilator through additional functionality in software and by use of the existing User Interface panel. No hardware or firmware changes or additions were required. The 840 Ventilator is a dual-microprocessor controlled, critical care ventilator intended to provide continuous ventilation for neonate to adult (with NeoMode Option) or infant to adult (without NeoMode Option) patients who require either invasive ventilation or non-invasive ventilation (via face mask).
{1}------------------------------------------------
### INDICATIONS FOR USE
#### 840 Ventilator System with Volume Ventilation Plus Option
The 840 Ventilator with Volume Ventilation Plus™ Option is used to provide continuous ventilation to patients requiring respiratory support. This device is used for a wide range of patients from infant to adult and for a wide variety of clinical conditions. The device is for prescription use only.
#### 840 Ventilator System with Neomode and Volume Ventilation Plus Options
The 840 Ventilator with Neomode and Volume Ventilation Plus™ Options provides continuous ventilation to patients requiring respiratoroy support. The Neomode Option, which is used on neonatal patients with Ideal Body Weights (IBW) as low as 0.5kg, is intended to cover a variety of clinical conditions. The 840 Ventilatory with Neomode and Volume Ventilation Plus Options is intended for use in hospital-type facilities. It may be used during hospital and hospital-type facility transport provided that electrical power and compressed gas are supplied. The device is for prescription use only.
### DETERMINATION OF SUBSTANTIAL EQUIVALENCE
The intended use of the 840 Ventilator with VV+ Option is the same as that for conventional, currently marketed, critical care ventilators with a VV+-like function. The materials and design of this device are similar to those of the predicate devices. The technical characteristics of the device modification do not introduce new questions regarding safety or effectiveness of critical care ventilators. Furthermore, the labeling associated with the 840 Ventilator with VV+ Option provides similar information as the predicate devices.
Information provided in this Special 510(k) submission provides comparative, predicate device information and describes development procedures that support the determination of substantial equivalence and assertion that the modified device is safe and effective for its intended use, Software design and development. (including verification testing, test and software quality procedures) were conducted using FDA`s Guidance for the Content of Pre-market Submissions for Software contained in medical devices, dated May 29, 1998, as a guidance and per internal company requirements.
In summary, Puritan-Bennett Corporation has provided information that indicates the 840 Ventilator with VV+ Option to be safe and effective. This device is considered to be substantially equivalent to currently marketed devices, incorporating a VV+-like function, that have been previously cleared by FDA.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing right, with flowing lines above them that resemble wings or feathers.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
# AUG 1 3 2002
Ms. Gina To Senior Regulatory Affairs Project Manager Puritan-Bennett Corporation 2200 Faraday Avenue Carlsbad, California 92008
Re: K021573
Trade/Device Name: 840 Ventilator System with Volume Ventilation Plus Option Regulation Number: 868.5895 Regulation Name: Continuous Ventilator Regulatory Class: II Product Code: CBK Dated: July 17, 2002 Received: July 18, 2002
Dear Ms. To:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{3}------------------------------------------------
Page 2 - Ms. To
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
Patacci Cocente /for,
Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
#### 510(k) Number: K021573
840 Ventilator System with Volume Ventilation Plus Option Device Name:
#### Indications For Use:
The 840 Ventilator with Volume Ventilation Plus™ Option is used to provide continuous ventilation to patients requiring respiratory support. This device is used for a wide range of patients from infant to adult and for a wide variety of clinical conditions.
#### 840 Ventilator System with Neomode and Volume Device Name: Ventilation Plus Options
Indications For Use:
The 840 Ventilator with Neomode and Volume Ventilation Plus™ Options provides continuous ventilation to patients requiring respiratoroy support. The Neomode Option, which is used on neonatal patients with Ideal Body Weights (IBW) as low as 0.5kg, is intended to cover a variety of clinical conditions. The 840 Ventilatory with Neomode and Volume Ventilation Plus Options is intended for use in hospitals and hospital-type facilities. It may be used during hospital and hospital-type facility transport provided that electrical power and compressed gas are supplied.
Prescription Use: Yes (per 21 CFR 801.109)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
f. A. Walter Johnson
ivision of Dental, Infection Cor and General Hospital De 510(k) Number